1 in 8 People in the U.S. Has Taken a GLP-1 Drug and Food Brands Are Taking Notice
"We see opportunity within our unique snacking portfolio," Tom McGough, co‐chief operating officer with Conagra Brands, told ...
Once Monthly Injectables To Become Future Therapeutic Options For Obesity: Report
From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting ...
Daily7h
GLP-1 RAs may reduce adverse effects in morbidly obese TKA patients: Study
A new study published in The Journal of Bone and Joint Surgery showed that when glucagon-like peptide-1 receptor agonist (GLP ...
Knowridge12h
Who should and should not embrace the latest weight-loss drugs
A person with a BMI over 35 and those who would like to lose more than 20 pounds is the ideal non-diabetic candidates for GLP ...